NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/16/2019
Back to search
Official data from USPTO
PHARMALIVE.COM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMALIVE.COM
ST13
US500000077393954Class
35
Filing
77393954
Registration
3688070
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
02/16/2019
Trademark type
Word
Nice classes
35
Filing date
02/11/2008
Registration date
09/29/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/16/2019
Last transaction
02/16/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2000-00-00
First use in commerce
2000-00-00
Drawing code
4
Owner type
16
Owner location
LIVINGSTON, NJ, US
Examiner
ABRAMS, JACKY
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
OUTCOMES LLC
Canon Communcations LLC
Representatives
OUTCOMES LLC
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
website featuring business information for and about the pharmaceutical industryinformation about clinical researchdevelopmentmarketing of pharmaceutical productsinformation about litigation and intellectual property news involving pharmaceutical products and pharmaceutical manufacturers and developersinformation about market research for pharmaceutical productsinformation about financial and business strategy news involving pharmaceutical manufacturers and developers
Publications
History of USPTO decisions and trademark events.
40 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/16/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/16/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/16/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/17/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
01/17/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/29/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/18/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/18/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/18/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/11/2015
E815
TEAS SECTION 8 & 15 RECEIVED
12/11/2015
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/27/2014
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/05/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/25/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/13/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/13/2012
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/09/2010
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/03/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
09/29/2009
PUBO
PUBLISHED FOR OPPOSITION
07/14/2009
APET
ASSIGNED TO PETITION STAFF
07/10/2009
NPUB
NOTICE OF PUBLICATION
06/24/2009
PAPER RECEIVED
06/19/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/05/2009
ALIE
ASSIGNED TO LIE
06/05/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/04/2009
IIOA
INADVERTENTLY ISSUED OFFICE ACTION
12/11/2008
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/11/2008
GNFR
FINAL REFUSAL E-MAILED
12/11/2008
CNFR
FINAL REFUSAL WRITTEN
12/11/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/22/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/21/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/21/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/21/2008
GNRT
NON-FINAL ACTION E-MAILED
05/21/2008
CNRT
NON-FINAL ACTION WRITTEN
05/21/2008
DOCK
ASSIGNED TO EXAMINER
05/21/2008
MPMK
NOTICE OF PSEUDO MARK MAILED
02/15/2008
NWAP
NEW APPLICATION ENTERED
02/14/2008
Continuous trademark protection
Get notified about every new filing that threatens PHARMALIVE.COM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.